Chlamydia Trachomatis is one of the more common sexually transmitted infections. The bacterial infection has a higher prevalence in populations aged 15-24, with women being most susceptible. Chlamydia infects the throat, rectum, cervix, and urethra. You are also susceptible to chlamydia in your eyes. Common symptoms of chlamydia are genital pain, sensations of burning during urination, pain during intercourse, abnormal amounts of viscous discharge from genitalia often accompanied by a putrid smell or pungent odor, and swollen/painful testicles. In many cases, individuals may not exhibit any symptoms with up to 30% of asymptomatic cases in females and 10% in males.
If chlamydia is left untreated, it may lead to serious health problems in the future including: PID (pelvic inflammatory disease) that damages/scars the reproductive system, infertility, increased chances of HIV/AIDS, ectopic pregnancies that result in miscarriages, premature births, pneumonia/conjunctivitis/eye infections in newborns, reactive arthritis, Fitz-Hugh-Curtis Syndrome, epididymitis, and prostate gland infection.
Chlamydia Trachomatis is tested in multiple screening panels provided by Solaris Diagnostics. STI panels, Women’s Health panels, and eye panels are all ran through the molecular lab for PCR resulting and verified by the microbiology lab. The polymerase chain reaction (PCR) technique involves amplifying bacterial DNA for identification and fast results.
The stigma surrounding sexually transmitted infections often leads to them not being talked about, and therefore, not being proactively dealt with. Early detection is vital to reducing the risk of complications. Solaris Diagnostics can provide detection of potential STI pathogens such as Chlamydia trachomatis with a turnaround time (TAT) of 24 hours.